Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Colombel

Showing results (241-250 of 368) with videos related to

Pageof 37
Sort By:
Alimentary Pharmacology & Therapeutics|July 9, 2011
Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel diseaseJ-F Rahier, S De Beauce, L Dubuquoy, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1991
[Transient ischemic colitis complicating sickle cell crisis]D Lucidarme, J F Colombel, J C Delesalle, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2001
Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease?A Cornet, T C Savidge, J Cabarrocas, et al.
Gut|August 1, 1989
Impaired bacterial flora in human excluded colonC Neut, J F Colombel, F Guillemot, et al.
The American Journal of Gastroenterology|August 5, 2000
Methotrexate in Crohn's disease: long-term efficacy and toxicityM Lémann, T Zenjari, Y Bouhnik, et al.
Gut|September 1, 1994
Inflammatory bowel disease in married couples: 10 cases in Nord Pas de Calais region of France and Liège county of BelgiumM C Comes, C Gower-Rousseau, J F Colombel, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1991
[Jejunal secretion of immunoglobulins and secretory component in three patients with primitive humoral immunoglobulin deficiency]D Lucidarme, J F Colombel, J P Vaerman, et al.
The Journal of Experimental Medicine|December 1, 1995
Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthmaB Wallaert, P Desreumaux, M C Copin, et al.
Alimentary Pharmacology & Therapeutics|October 19, 2013
Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERER Panaccione, J-F Colombel, W J Sandborn, et al.
Gastroenterology|July 1, 1997
Distinct cytokine patterns in early and chronic ileal lesions of Crohn's diseaseP Desreumaux, E Brandt, L Gambiez, et al.
Pageof 37

Showing results (241-250 of 368) with videos related to

Sort By:
Pageof 37
Alimentary Pharmacology & Therapeutics|July 9, 2011
Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel diseaseJ-F Rahier, S De Beauce, L Dubuquoy, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1991
[Transient ischemic colitis complicating sickle cell crisis]D Lucidarme, J F Colombel, J C Delesalle, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2001
Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease?A Cornet, T C Savidge, J Cabarrocas, et al.
Gut|August 1, 1989
Impaired bacterial flora in human excluded colonC Neut, J F Colombel, F Guillemot, et al.
The American Journal of Gastroenterology|August 5, 2000
Methotrexate in Crohn's disease: long-term efficacy and toxicityM Lémann, T Zenjari, Y Bouhnik, et al.
Gut|September 1, 1994
Inflammatory bowel disease in married couples: 10 cases in Nord Pas de Calais region of France and Liège county of BelgiumM C Comes, C Gower-Rousseau, J F Colombel, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1991
[Jejunal secretion of immunoglobulins and secretory component in three patients with primitive humoral immunoglobulin deficiency]D Lucidarme, J F Colombel, J P Vaerman, et al.
The Journal of Experimental Medicine|December 1, 1995
Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthmaB Wallaert, P Desreumaux, M C Copin, et al.
Alimentary Pharmacology & Therapeutics|October 19, 2013
Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERER Panaccione, J-F Colombel, W J Sandborn, et al.
Gastroenterology|July 1, 1997
Distinct cytokine patterns in early and chronic ileal lesions of Crohn's diseaseP Desreumaux, E Brandt, L Gambiez, et al.
Pageof 37